Connect with us


Medical Cannabis – Can It Help Treat Asthma?



medical cannabis

The legalization of the cannabis industry and the increased popularity of medical cannabis has raised some questions. Consumers are curious about the healing power of medicinal cannabis, and whether or not, it can treat asthma. Asthma is a lung disease that affects individuals and causes the narrowing or inflammation of the airways. Common symptoms may include difficulty breathing, coughing, and wheezing.

Asthma, sadly, has no cure. However, many treatment options are available to manage the symptoms and prevent further complications. Moreover, researchers are intrigued by the connection between medicinal cannabis and asthma. The question though is the consumption method. Most people smoke cannabis, which isn’t a very healthy option for asthma patients.

Medical cannabis

Studies show that specific components of cannabis can be potentially beneficial for asthma patients. Medicinal cannabis can be a reference to the entire plant or a specific beneficial component which later forms the medication. However, to understand the difference between medicinal cannabis and recreational cannabis is essential.

Medical cannabis uses specific cannabinoids to interact with the endocannabinoid system of the body, to target specific responses. Medical cannabis is widely used to treat and/or alleviate the symptoms of a lot of different issues, which can include, depression, anxiety, menopause, endometriosis, PTSD, cancer, inflammation, arthritis, etc.

A lot of people smoke cannabis for recreational purposes. However, this can negatively affect the lungs, which can be a further complication for asthma patients. Smoking of any kind can cause irritation to the lungs, of a healthy individual as well, which can lead to further complications.

The use of medicinal cannabis in other forms can add more benefits and safety for asthma patients. Multiple options can also include consumption of cannabis or extracts in tea or food (commonly known as edibles), consumption of the active and primary ingredients in the form of capsules, and the application of topical preparations right onto the skin.


Cannabis generally contains various active compounds commonly known as cannabinoids. These compounds also include the most popular cannabinoids, CBD (cannabidiol) and THC (tetrahydrocannabinol). THC is primarily a psychoactive compound. Unlike CBD, it gives the feeling of high or a sense of euphoria. CBD does not produce any mind-altering effects.

CBD and THC are one of the many compounds in cannabis that can provide several health benefits. The anti-spasmodic and anti-inflammatory properties are examples. Some individuals use cannabis in an attempt to treat chronic illnesses that cause inflammation and pain, like multiple sclerosis (MS). While many countries have legally approved the use of medicinal cannabis for these purposes, the United States did not participate.

Researchers have studied the safety of cannabis for patients suffering from asthma and other inflammatory conditions. An animal study from 2015, showed that CBD could be potentially beneficial for asthmatic patients due to its anti-inflammatory properties. The FDA (U.S Food and Drug Administration), however, has not legally declared the use of medicinal cannabis for asthma.


Currently, there is a lack of substantial evidence to construct a conclusive outcome that would ensure the safety and effectiveness of medical cannabis for asthma. Although, there is a possibility that the anti-spasmodic and anti-inflammatory properties of medical cannabis could alleviate the symptoms of asthma. In June 2018, the use of a pure form of CBD was approved by the FDA.

The FDA also approved Epidolex, which was a drug used for the treatment of 2 severe but rare forms of epilepsy. these forms of epilepsy usually do not interact with any other medication. Research shows the ability of THC to suppress the body’s immune system. This further helps in t reduction of the symptoms projected from autoimmune diseases, one of which is asthma. As asthma is typically an allergic reaction the over-reaction of the immune system is caused due to a triggering environment.

Studies show that a form of THC may potentially have bronchodilator properties, hence, help to make breathing easier for asthmatic patients. However, commonly it can prove to be difficult to study the impact of cannabis and its compounds. This is due to the reason that most people using cannabis, tend to use the entire plant by regularly smoking. This makes the assessment of the compounds and their positive effects, harder.


Although beneficial, there might be some risks involved. Studies have shown that smoking cannabis can potentially trigger an asthma attack, as any other form of smoking. It may also develop further risks of allergies. Smoking cannabis while suffering from an asthma attack could cause irritation in the lungs, heighten health risks, and worsen coughing.

However, for medical cannabis in non-smoking alternatives, there may be side effects including

  • fluctuations in mood and perception
  • lessened coordination
  • difficulty in remembering, reasoning, and thinking

A doctor’s supervision and advice are essential when using medical cannabis, to minimize the risks.

Legal issues

The laws surrounding cannabis, for both medical and recreational purposes, are constantly evolving with new changes. While some states and countries have legalized cannabis for both purposes, many have only legalized medical cannabis, while others haven’t legalized either. Hence it is important to check your state and federal laws before trying to obtain and/or use cannabis.

Many forms of medical cannabis, like CBD oil, are legal. However, there are restrictions involved and a need for prescriptions. CBD oil and many cannabis products that do not require FDA approval, are not regulated either. This can cause further ambiguity regarding the contents of the cannabis product. Furthermore, cannabis is not approved by the FDA, for treating asthma.

Like any other medication, a consultation with a licensed doctor is necessary. Any additional treatments for any chronic illnesses, like asthma, should be consulted with a doctor, to understand drug-to-drug interactions, along with the risks and side effects involved.

Since medical cannabis can have potential risks associated as well, a licensed doctor is the best individual to refer to, for a better understanding regarding the effectiveness of the treatment.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Cannabis Oil Effectively Reduces Chronic Pain



The use of cannabis oil and other medical items containing marijuana legal since 2018 in the UK. However, the evidence of marijuana being efficacious has come under light recently. Researchers are discovering the effectiveness of marijuana oil in chronic pain patients.

Multiple studies occurred to determine the effectiveness of cannabis oil. Patients receiving marijuana as part of their treatment feel much better and experience improvement in their health.

Gathering Evidence Of Cannabis Oil Being Effective For Chronic Pain Patients

The United Kingdom Medical Cannabis Registry enrolls one hundred and ten patients. The purpose of enrolling these patients was to observe the effectiveness of cannabis oil. Moreover, through these patients, the impact of marijuana on overall improving quality of life was determined.

ALSO READ: New York Cannabis Board Relaxes Medical Cannabis Rules

The registry reports that enrolled patients feel much better after one, three, and six months of cannabis oil intake. They experience that their pain reduces after using medical pot. They experience comfort, and their sleep quality has improved hugely. According to the registry, there are significant improvements in patients’ health-associated quality of life.

The National Health Service of the United Kingdom has a strict cannabis oil prescription policy. It is hard for patients to get a marijuana prescription because of the strict rules of the NHS. Patients who don’t respond well to conventional therapy have access to medical marijuana. The conditions under which patients can access medical marijuana include pain sufferers, individuals with anxiety issues, and multiple sclerosis.

About sixty-five percent of the patients part of the study had never used cannabis oil or medical marijuana. The participants are primarily diagnosed with chronic non-cancer pain, neuropathic pain, and fibromyalgia.

16% of the participants suffered from fibromyalgia and 48% percent from chronic non-cancer pain. Twenty-four percent of the participants are suffering from neuropathic pain.

Experts Focus On Research

For the betterment of society and its safety, it is vital to gather research-based evidence. Doctors and scientists consider it essential to discover the realities of using cannabis before prescribing it.

Dr. Simon Erridge is the head of research at Sapphire Medical Clinics. In a statement, he said that the number of medical marijuana prescriptions is increasing quickly in the UK. In this situation, it is essential to determine the outcomes of patients. Collecting real-world practical evidence regarding cannabis oil consumption is vital.

According to Dr. Simon, this research that they conducted is one of a kind in Europe. His team will continuously review inpatients, outpatients, and marijuana products via the Medical Cannabis Registry UK. So far, the selection of observational data has occurred. In the future, more critical research, including randomized controlled investigations, will occur.

Sapphire Medical Clinics developed the registry. They survey patients suffering from various diseases receiving separate prescriptions depending upon their condition. Surveying these individuals enables us to reduce the knowledge gap.

Filling the blank space regarding medical marijuana and cannabis oil in scientific knowledge helps a lot. The study’s findings were published in the well-known scientific journal, the Journal of Clinical Pharmacology.

The research does prove that medical marijuana is effective in improving multiple conditions of people. But researchers require more research to form guidelines, funders, and licensing agencies.

Adven is a subsidiary of Curaleaf International. It is one of the largest independent marijuana companies in Europe. Adven cannabis oil was used in studies such that the average CBD dose was 20mg per day. The average THC dose that participants get is 1mg per day. Administration of cannabis oil occurs in a ratio CBD/THC of 20 to 1.

More participants enrolled in the survey process. Sapphire Medical Clinic plans to continue its survey-based research.

Continue Reading


Oklahoma On Its Way To Legalize Marijuana And Alter Medical Cannabis Reforms 



Oklahoma cannabis legal

Activists in Oklahoma are filling marijuana legalization. For the 2022 ballot, they are willing to introduce medical cannabis reform. On Thursday, the activists of the state legalized adult-use weed products. Moreover, they remodel the existing medical pot program of the state.

The activists formally introduced the measures to the secretary of state’s office. After the signature-gathering, the constitutional amendments will occur.

ALSO READ: Cannabis Oil Effectively Reduces Chronic Pain

Last month, Oklahomans for Responsible Cannabis Action (ORCA) announced late that it was close to finalizing the language of the initiatives. The final set of amendments occurs after soliciting feedback from a wide range of advocates and stakeholders.

Medical Cannabis Reforms 

Medical cannabis reforms in the state have many flaws and loopholes that lead to problems. Jed Green is the director of ORCA. According to Jed, the initiatives the activists are introducing are to fix the issues that have emerged in the state’s medical marijuana program.

The amendments and new policies will also generate opportunities for the weed industry with adult-use legalization. According to Jed, these initiatives will enable the people of Oklahomans to keep operating the marijuana business successfully.

New Marijuana Policies

Under the new policy, individuals 21 or above will have permission to keep eight ounces of marijuana. They can purchase such an amount from any legal retailer or dispenser. The new policy also allows one person to own 12 plants of cannabis for personal use.

The new reforms suggest imposing a fifteen percent excise tax on the sale of weed products. There are multiple numbers of programs that will receive revenue generated from those taxes.

After deducting the implementation cost, the rest of the money is divided into various programs. These programs include water-related infrastructure, substance misuse treatment programs, people with abnormalities or disabilities, and many more.

Some of the revenue money will be for law enforcement training and cannabis research projects. The initiatives have measures for those that have faced resentencing for marijuana convictions.

What is new in Oklahoma Medical Cannabis Reforms?

In 2018 voters in Oklahoma approved medical cannabis programs are open for any patient. Unlike other states, Oklahomans patients do not need to fulfill specific qualifying conditions. In addition, physicians and doctors can prescribe medical weed products to anyone they think is fit to use.

Activists suggest establishing a new OSCC Oklahoma Cannabis Commission. The aim of establishing the OSCC is to build a commission that will oversee everything regarding the state medical marijuana program.

The new policy also suggests imposing a seven percent excise tax. The authorities will utilize revenue money from the sale of these items in supporting weed research. It will be for rural impact and urban waste remediation.

Part of the revenue will also be for agriculture development and treatment programs designed for substance use disorder patients. Gross income from the sale of medical cannabis will support mental health response programs.

The tax on medical hemp products will decrease to zero gradually within one year of the enactment of initiatives. Once the proposed constitution is under-enactment, medical marijuana dispensaries will have permission to sell recreational pot items. However, it will begin within 60 days of ordinance enactment.

The activists have previously attempted to qualify some cannabis legalization measures for the 2020 ballot. But, due to less support, those measures were never put to action. To get signatures of the majority to approve ballot 2022 is essential to introduce the new medical cannabis reforms and legalize marijuana for adult use.

Without sufficient support from registered voters, new policies can never become a reality.

Continue Reading


New York Cannabis Board Relaxes Medical Cannabis Rules



Cannabis Companies Making Moves Before New York Begins Recreational Cannabis Sales

New York State approves recreational and medical cannabis by passing the bill of decriminalizing and legalizing marijuana. Initially, the process got delayed, but now things are moving a step forward in implementing the bill. Governor Andrew Cuomo and legislators approve of the marijuana control board.


The cannabis control board, after its formation, conducted its first meeting on Tuesday. Five members of the board are taking a step closer to the commencement of legalized marijuana retail sales. 


What Changes Does The State Cannabis Board Make?


The members agree to make an official announcement of immediately relaxing rules governing the state’s medical-marijuana program. The control board expands the number of people who can prescribe medical cannabis. Now anyone from dentists to midwives can prescribe marijuana as medication. 

ALSO READ: Not All Cannabis Firms Favors Federal Cannabis Legalization

The control board permits the sale of weed flowers. It will make the drug available to people in a smokeable format. Moreover, it will lower the high prices of medical weed items in New York. 


Tremaine Wright is the chair of the NewYork State’s Cannabis Control Board. The mandate of the board is to make medical marijuana accessible for patients and improve patient care. Tremaine elaborates that the board takes their mandate very seriously and will immediately work on fulfilling it. 


Changes In The Medical Cannabis Program


In the first quarter of 2021, legislators made some changes to the medical marijuana program. Previously, the program authorized 150000 New Yorkers to only get access to medical cannabis for various health reasons. It is uncertain how many of the certified people are still using pot. It is unknown how many have died of terminal diseases. 


Of the certified people, some people have abandoned the use of marijuana due to cost issues. Some stopped their program because of the inaccessibility of weed in New York.


Lawmakers urge the control board not to delay medical cannabis program changes. Crystal Peoples-Stokes is the Assembly Majority Leader. Stokes, the Assembly marijuana law sponsor, and a Buffalo Democrat were among those who requested quick changes. Legislators are requested to make the necessary changes to the program before beginning the process of allowing recreational marijuana sales. 


Decisions regarding recreational pot, policymaking, and implementation of its rules can occur within 18 months. The state has time of 18 months before recreational marijuana sales begin in New York State. But before that, rules regarding pot as medication must undergo some alterations immediately.  


What More Is On Marijuana?


The Office of Cannabis Management has decriminalized for people 21 and older the ownership of about 3 ounces of marijuana. However, the sale of weed is still illegal in the state. The control board or agency also controls the hemp industry along with the recreational and medical cannabis industry. 


About 3400 healthcare professionals have permission to prescribe medical marijuana to patients that are certified or eligible. These professionals include physicians, nurse practitioners, dentists, midwives, and some assistants of physicians.

ALSO READ: Justin Bieber Gets Cannabis From California, And Launch Pre-rolled Joints – “Peaches”

The change that led to the expansion of health care professionals who can prescribe medical marijuana passed on Tuesday. It increases the number of prescribers that are recommending the drug. Now anyone with a license to dispense controlled substances can prescribe medical cannabis. 


The board increases the supply of marijuana for dispensing. It decreases the $50 registration fee of the patient and caregiver. It makes it easy for facilities such as hospitals to hand out medical cannabis to patients.


According to officials, allowing the sale of raw flowers instead of refined final formulations of marijuana will decrease production costs. As a result, it will reduce the cost of medical cannabis for patients. However, the entire marijuana plant sale will not begin on the 38 medical pot dispensaries right away. They will have to practice some quality control measures to start selling the drug. 

Continue Reading


error: Content is protected !!